BB
Insider selling
Bruce Booth sold $56.5M of Kymera Therapeutics, Inc. (KYMR) stock
Bruce Booth, Dir of Kymera Therapeutics, Inc. (KYMR), sold 513,245 shares of KYMR stock worth $56.5M, per an SEC Form 4 filed Jun 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 26, 2026, 4 days before it was made public.
KYMR has moved +8.8% since the trade date, from $108.12 to $117.67 (Sep 21, 2026 close).
- Traded
- Jun 26, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 4 days
- Price since
- +8.8%
- Role
- Dir
- Source
- SEC Form 4
More KYMR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.